HOME >> BIOLOGY >> NEWS
Regardless of global warming, rising CO2 levels threaten marine life

CHAMPAIGN, Ill. -- Like a piece of chalk dissolving in vinegar, marine life with hard shells is in danger of being dissolved by increasing acidity in the oceans.

Ocean acidity is rising as sea water absorbs more carbon dioxide released into the atmosphere from power plants and automobiles. The higher acidity threatens marine life, including corals and shellfish, which may become extinct later this century from the chemical effects of carbon dioxide, even if the planet warms less than expected.

A new study by University of Illinois atmospheric scientist Atul Jain, graduate student Long Cao and Carnegie Institution scientist Ken Caldeira suggests that future changes in ocean acidification are largely independent of climate change. The researchers report their findings in a paper accepted for publication in the journal Geophysical Research Letters, and posted on its Web site.

"Before our study, there was speculation in the academic community that climate change would have a big impact on ocean acidity," Jain said. "We found no such impact."

In previous studies, increasing levels of carbon dioxide in the atmosphere led to a reduction in ocean pH and carbonate ions, both of which damage marine ecosystems. What had not been studied before was how climate change, in concert with higher concentrations of carbon dioxide, would affect ocean chemistry and biology.

To investigate changes in ocean chemistry that could result from higher temperatures and carbon-dioxide concentrations, the researchers used an Earth-system model called the Integrated Science Assessment Model. Developed by Jain and his graduate students, the model includes complex physical and chemical interactions among carbon-dioxide emissions, climate change, and carbon-dioxide uptake by oceans and terrestrial ecosystems.

The ocean-surface pH has been reduced by about 0.1 during the past two centuries. Using ISAM, the researchers found ocean pH would decline a total of 0.31 by the
'"/>

Contact: James E. Kloeppel
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
8-Mar-2007


Page: 1 2 3

Related biology news :

1. Revolutionary global environment fund announces $50M expansion
2. 1,000-year-old Arctic ponds disappearing due to global warming
3. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
4. Scientists call for global push to advance research in synthetic biology
5. Northern forests less effective than tropical forests in reducing global warming
6. UN issues analysis of global investors sustainable energy gold rush
7. Gannet population under threat from global warming
8. Yale journal examines the global impact of cities
9. Researchers examine carbon capture and storage to combat global warming
10. QUT microgravity tower attracts global scientific community
11. Study warns climate change and deforestation will lead to declines in global bird diversity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Regardless global warming rising levels threaten marine life

(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: